论文信息 - 758OSELINEXOR (KPT-330), AN ORAL, SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SHOWS ANTI-PROSTATE CANCER (PRCA) ACTIVITY PRECLINICALLY & DISEASE CONTROL IN PATIENTS (PTS) WITH CHEMOTHERAPY REFRACTORY, CASTRATE-RESISTANT PROSTATE CANCER (CRPC). - 字舞流文

758OSELINEXOR (KPT-330), AN ORAL, SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SHOWS ANTI-PROSTATE CANCER (PRCA) ACTIVITY PRECLINICALLY & DISEASE CONTROL IN PATIENTS (PTS) WITH CHEMOTHERAPY REFRACTORY, CASTRATE-RESISTANT PROSTATE CANCER (CRPC).

A. Shields | M. Mirza | B. Klebanov | N. Gabrail | S. Maity | J. Araujo | S. Shacham | A. Mahipal | R. Carlson | M. Kauffman | J. Gericitano | H. Mahaseth | T. Rashal | E. Shacham | D. Vincent